Paper28034992
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone.
Lidonnici MR and 15 others. Haematologica, 2017. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone. Papers, record 28034992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28034992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemokine CXCL12 | Major topic |
| Granulocyte Colony-Stimulating Factor | Major topic |
| Hematopoietic Stem Cell Mobilization | Major topic |
| Heterocyclic Compounds | Major topic |
| Receptors, CXCR4 | Major topic |
| Stem Cell Niche | Major topic |
| Animals | |
| Antigens, CD34 | |
| Benzylamines | |
| Cell Cycle Proteins | |
| Cyclams | |
| Drug Combinations | |
| Endonucleases | |
| Gene Expression Profiling | |
| Gene Expression Regulation | |
| Hematopoietic Stem Cell Transplantation | |
| Hematopoietic Stem Cells | |
| Humans | |
| Immunophenotyping | |
| Leukapheresis | |
| Mesenchymal Stem Cells | |
| Mice | |
| Protein Binding | |
| Signal Transduction | |
| beta-Thalassemia |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21737740 | Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. | Science | 2011 | https://conductscience.org/library/papers/21737740 | PubMed |
| 2 | 17382247 | Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. | Biol Blood Marrow Transplant | 2007 | https://conductscience.org/library/papers/17382247 | PubMed |
| 3 | 24001178 | Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with β-thalassemia major. | Hum Gene Ther | 2013 | https://conductscience.org/library/papers/24001178 | PubMed |
| 4 | 12393558 | Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. | Blood | 2003 | https://conductscience.org/library/papers/12393558 | PubMed |
| 5 | 19602709 | Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures. | Blood | 2009 | https://conductscience.org/library/papers/19602709 | PubMed |
| 6 | 12815382 | The bicyclam AMD3100 story. | Nat Rev Drug Discov | 2003 | https://conductscience.org/library/papers/12815382 | PubMed |
| 7 | 15837815 | Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. | J Exp Med | 2005 | https://conductscience.org/library/papers/15837815 | PubMed |
| 8 | 24319662 | Transcriptome analysis identifies regulators of hematopoietic stem and progenitor cells. | Stem Cell Reports | 2013 | https://conductscience.org/library/papers/24319662 | PubMed |
| 9 | 25753525 | Mild Heat Treatment Primes Human CD34(+) Cord Blood Cells for Migration Toward SDF-1α and Enhances Engraftment in an NSG Mouse Model. | Stem Cells | 2015 | https://conductscience.org/library/papers/25753525 | PubMed |
| 10 | 16439684 | AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. | Blood | 2006 | https://conductscience.org/library/papers/16439684 | PubMed |
| 11 | 16863911 | The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics. | Exp Hematol | 2006 | https://conductscience.org/library/papers/16863911 | PubMed |
| 12 | 21460243 | Twenty-five years of peripheral blood stem cell transplantation. | Blood | 2011 | https://conductscience.org/library/papers/21460243 | PubMed |
| 13 | 21886173 | Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. | Leukemia | 2012 | https://conductscience.org/library/papers/21886173 | PubMed |
| 14 | 19363221 | Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. | Blood | 2009 | https://conductscience.org/library/papers/19363221 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42552339 | Development of an investigational medicinal stem cell gene therapy product to attempt curing human immunodeficiency virus infection. | Sci Rep | 2026 | https://conductscience.org/library/papers/42552339 | PubMed |
| 42463828 | Update of the decision-making algorithm on selecting transfusion-dependent β-thalassemic patients for gene therapy approaches: joint consensus report on behalf of EHA-specialized working group and EBMT hemoglobinopathies working party. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42463828 | PubMed |
| 40833555 | Mapping Hematopoietic Fate after Transplantation. | Stem Cell Rev Rep | 2025 | https://conductscience.org/library/papers/40833555 | PubMed |
| 39961646 | Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's disease. | Gut | 2025 | https://conductscience.org/library/papers/39961646 | PubMed |
| 39442556 | Long-term lineage commitment in haematopoietic stem cell gene therapy. | Nature | 2024 | https://conductscience.org/library/papers/39442556 | PubMed |
| 39314524 | Correction of osteopetrosis in the neonate oc/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39314524 | PubMed |
| 39223325 | Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells. | Nat Biotechnol | 2025 | https://conductscience.org/library/papers/39223325 | PubMed |
| 39168923 | Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs). | Stem Cell Rev Rep | 2024 | https://conductscience.org/library/papers/39168923 | PubMed |
| 38235620 | An evidence-based and risk-adapted GSF versus GSF plus plerixafor mobilization strategy to obtain a sufficient CD34+ cell yield in the harvest for autologous stem cell transplants. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38235620 | PubMed |
| 37591714 | Circulating IRF8-expressing CD123+CD127+ lymphoid progenitors: key players in human hematopoiesis. | Trends Immunol | 2023 | https://conductscience.org/library/papers/37591714 | PubMed |
| 37460391 | Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation. | Br Med Bull | 2023 | https://conductscience.org/library/papers/37460391 | PubMed |
| 37274742 | Targeting the stem cell niche micro-environment as therapeutic strategies in aging. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37274742 | PubMed |
| 37244942 | Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy. | Nat Commun | 2023 | https://conductscience.org/library/papers/37244942 | PubMed |
| 37198402 | New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine. | Cell Mol Immunol | 2023 | https://conductscience.org/library/papers/37198402 | PubMed |
| 36407494 | Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseases. | Front Genome Ed | 2022 | https://conductscience.org/library/papers/36407494 | PubMed |
| 34408144 | DL4-μbeads induce T cell lineage differentiation from stem cells in a stromal cell-free system. | Nat Commun | 2021 | https://conductscience.org/library/papers/34408144 | PubMed |
| 34166998 | Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease. | Blood Cells Mol Dis | 2021 | https://conductscience.org/library/papers/34166998 | PubMed |
| 33969274 | Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. | Hemasphere | 2021 | https://conductscience.org/library/papers/33969274 | PubMed |
| 33635334 | Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells. | Blood Adv | 2021 | https://conductscience.org/library/papers/33635334 | PubMed |
| 33614648 | Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33614648 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28034992
GET https://conductscience.org/api/papers/v1/28034992/cited_by?page=2